Nicholas Broughton, DO
Undersea and Hyperbaric Medicine · Plano, TXNPI 1164042339
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 29 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 18 manufacturers, the largest accounting for just 17.7% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2024 at $453 and has fallen 62.8% since, to $169 in 2025. That places this record below the midpoint for undersea and hyperbaric medicine clinicians in TX, where the typical reported total is $844.
Across 29 payments — averaging $23.22 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Smith+Nephew$119
- Paratek Pharmaceuticals, Inc.$72
- Urgo Medical North America, LLC$71
- OVIK Health, LLC$70
- AbbVie$48
- Mimedx Group, Inc.$37
- plus $257 from 12 others
What the payments were for
- Food & beverage$673100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Smith+Nephew | 6 | $119 |
| Paratek Pharmaceuticals, Inc. | 4 | $72 |
| Urgo Medical North America, LLC | 2 | $71 |
| OVIK Health, LLC | 2 | $70 |
| AbbVie | 2 | $48 |
| Mimedx Group, Inc. | 1 | $37 |
| Integra Lifesciences Corporation | 1 | $33 |
| Reprise Biomedical, Inc. | 1 | $32 |
| Kerecis Limited | 1 | $29 |
| Inari Medical, Inc. | 1 | $29 |
| Pylant Medical | 1 | $27 |
| Fidia Pharma USA Inc. | 1 | $22 |
| Globus Medical | 1 | $19 |
| Solventum Corporation | 1 | $19 |
| Sun Pharmaceutical Industries Inc. | 1 | $16 |
| Musculoskeletal Transplant Foundation Inc. | 1 | $14 |
| Advanced Oxygen Therapy Inc. | 1 | $11 |
| Organon | 1 | $5 |
How this compares
$673 in reported general payments places this provider in the 40th percentile of 59 undersea and hyperbaric medicine providers in Texas.
See all undersea and hyperbaric medicine providers in Texas →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gentamicin Sulfate | 74 | $2,152 |
| Doxycycline Hyclate | 31 | $383 |
| Doxycycline Monohydrate | 23 | $283 |
| Ciprofloxacin Hcl | 20 | $222 |
| Mupirocin | 11 | $110 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 13 | $62 |
Paid to pharmacies, not to this prescriber.
Other undersea and hyperbaric medicine in Plano
- Christine DesocarrazPlano$19
- Wade FarrowCollege Station$2.2M
- Timothy BumannAbilene$154K
- Heather AguirreSan Antonio$98K
- Ronald ScottFrisco$76K
- Andrew ApplewhiteDallas$46K
- Joseph WolcottLubbock$38K
- Noel OliveiraEdinburg$33K
- Maria AguinagaMission$18K
- Jayesh ShahSan Antonio$17K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.